A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity

Biochemical and Biophysical Research Communications

Volumn 308, Issue 1, 2003, Pages 106-113

  Miyazaki, Kou ^a   Ozaki, Toshinori ^a   Kato, Chiaki ^a   Hanamoto, Takayuki ^a   Fujita, Tomoyuki ^a   Irino, Shigemi ^a   Watanabe, Ken Ichi ^a   Nakagawa, Takahito ^a   Nakagawara, Akira ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

E3 ubiquitin ligase; NEDL2; p53; p73; PY motif; WW domain

Indexed keywords

BACTERIAL PROTEIN; PROTEIN DERIVATIVE; PROTEIN NEDL2; PROTEIN P73; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL CELL; CATALYSIS; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; TRANSCRIPTION INITIATION;

BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 0042349285     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01347-0     Document Type: Article

References (33)

1. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.C., Valent A., Minty A., Chalon P., Lelias J.M., Dumont X., Ferrara P., McKeon F., Caput D. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 90:1997;809-819.
2. Jost C.A., Marin M.C., Kaelin W.G. p73 is a human p53-related protein that can induce apoptosis. Nature. 389:1997;191-194.
3. Fang L., Lee S.W., Aaronson S.A. Comparative analysis of p73 and p53 regulation and effector functions. J. Cell Biol. 147:1999;823-830.
4. De Laurenzi V., Costanzo A., Barcaroli D., Torrinoni A., Falclco M., Annicchiarico-Petruzzelli M., Levrero M., Melino G. The new p73 splice variants, γ and δ, with different transcriptional activity. J. Exp. Med. 188:1998;1763-1768.
5. Ueda Y., Hijikata M., Takagi S., Chiba T., Shimotohno K. New p73 variants with altered C-terminal structures have varied transcriptional activities. Oncogene. 18:1999;4993-4998.
6. De Laurenzi V., Catanl M.V., Teminoni A., Corazzari M., Melino G., Costanzo A., Levrero M., Knight R.A. Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ Cell Death Differ. 6:1999;389-390.
7. Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., McKeon F., Caput D. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature. 404:2000;99-103.
8. Pozniak C.D., Radinovic S., Yang A., McKeon F., Kaplan D.R., Miller F.D. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science. 289:2000;304-306.
9. Stiewe T., Zimmermann S., Frilling A., Esche H., Putzer B.M. Transactivation-deficient ΔTA-p73 acts as an oncogene. Cancer Res. 62:2002;3598-3602.
10. Grob T.J., Novak U., Maisse C., Barcaroli D., Luthi A.U., Pirnia F., Hugli B., Graber H.U., De L.V., Fey M.F., Melino G., Tobler A. Human ΔNp73 regulates a dominant negative feedback loop for TAp73 and p53. Cell Death Differ. 8:2001;1213-1223.
11. Nakagawa T., Takahashi M., Ozaki T., Watanabe K., Todo S., Mizuguchi H., Hayakawa T., Nakagawara A. Autoinhibitory regulation of p73 by ΔNp73 to modulate cell survival and death through p73-specific target element within the ΔNp73 promoter. Mol. Cell. Biol. 22:2002;2575-2585.
12. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 387:1997;296-299.
13. Kubbutat M.H.G., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature. 387:1997;299-303.
14. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:1997;25-27.
15. Vousden K.H. Activation of the p53 tumor suppressor protein. Biochem. Biophys. Acta. 1602:2002;47-59.
16. Balint E., Bates S., Vousden K.H. Mdm2 binds p73α without targeting degradation. Oncogene. 18:1999;3923-3929.
17. Zeng X., Chen L., Jost C.A., Maya R., Keller D., Wang X., Kaelin W.G., Oren M., Chen J., Lu H. MDM2 suppresses p73 function without promoting p73 degradation. Mol. Cell. Biol. 19:1999;3257-3266.
18. Gong J., Costanzo A., Yang H.Q., Melino G., Kaelin W.G., Levrero M., Wang J.Y.J. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 399:1999;806-809.
19. Steegenga W.T., Shvarts A., Riteco N., Bos J.L., Jochemsen A.G. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins. Mol. Cell. Biol. 19:1999;3885-3894.
20. Nagase T., Kikuno R., Ishikawa K.I., Ohara O. Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 7:2000;65-73.
21. Hatakeyama S., Jensen J.P., Weissman A.M. Subcellular localization and ubiquitin-conjugating enzyme (E2) interactions of mammalian HECT family ubiquitin protein ligases. J. Biol. Chem. 272:1997;15085-15092.
22. Strano S., Munarriz E., Rossi M., Cristofanelli B., Shaul Y., Castagnoli L., Levine A.J., Sacchi A., Cesareni G., Oren M., Blandino G. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 275:2000;29503-29512.
23. Lee C.-W., La Thangue N.B. Promoter specificity and stability control of the p53-related protein p73. Oncogene. 18:1999;4171-4181.
24. Ohtsuka T., Ryu H., Minamishima Y.A., Ryo A., Lee S.W. Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation. Oncogene. 22:2003;1678-1687.
25. Pirozzi G., McConnell S.J., Uveges A.J., Carter J.M., Sparks A.B., Kay B.K., Fowlkes D.M. Identification of novel human WW domain-containing proteins by cloning of ligand targets. J. Biol. Chem. 272:1997;14611-14616.
26. Zhu H., Kavsak P., Abdollah S., Wrana J.L., Thomsen G.H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 400:1999;687-693.
27. Qiu L., Joazeiro C., Fang N., Wang H.-Y., Elly C., Altman Y., Fang D., Hunter T., Liu Y.-C. Recognition and ubiquitination of Notch by Itch, a Hect-type E3 ubiquitin ligase. J. Biol. Chem. 275:2000;35734-35737.
28. Spence J., Gali R.R., Dittmar G., Sherman F., Karin M., Finley D. Cell cycle regulated modification of the ribosome by a variant multiubiquitin chain. Cell. 102:2000;67-76.
29. Deng L., Wang C., Spencer E., Yang L., Braun A., You J., Slaughter C., Pickart C., Chen Z.J. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell. 103:2000;351-361.
30. Deveraux Q., Ustrell V., Pickart C., Rechsteiner M. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269:1994;7059-7061.
31. Agami R., Blandino G., Oren M., Shaul Y. Interaction of c-Abl and p73α and their collaboration to induce apoptosis. Nature. 399:1999;809-813.
32. Ren J., Datta R., Shioya H., Li Y., Oki E., Biedermann V., Bharti A., Kufe D. p73β is regulated by protein kinase Cδ catalytic fragment generated in the apoptotic response to DNA damage. J. Biol. Chem. 277:2002;33758-33765.
33. Takada N., Ozaki T., Ichimiya S., Todo S., Nakagawara A. Identification of a transactivation activity in the COOH-terminal region of p73 which is impaired in the naturally occurring mutants found in human neuroblastomas. Cancer Res. 59:1999;2810-2814.